Bailout Palmaz‐Schatz coronary stenting in 39 patients with occlusive dissection complicating conventional Angioplasty

Abstract
The purpose of this study was to evaluate feasibility, safety, and efficacy of bailout Palmaz‐Schatz stenting in a series of 39 patients with coronary dissection associated with acute or unequivocal threatened closure complicating conventional angioplasty. No anatomical characteristics other than reference vessel diameter < 3 mm were considered as contraindications for bailout coronary stenting. Stringent criteria were adopted in defining optimal results (10% residual stenosis or angiographic evidence of residual dissection), deployment failure (failure to deploy the stent because of poor trackability or persistent occlusion despite stent deployment). A total of 49 stents and 7 half‐stents were implanted in 36 patients (range 1–5; mean 1.45 ± 0.84). Successful stenting without in‐hospital death, urgent or semielective coronary surgery, stent thrombosis, or Q‐wave myocardial infarction was achieved in 33/39 patients (85%). A suboptimal result was associated with an increased risk of in‐hospital recurrence of ischemia and other related major adverse events (2/5 patients with suboptimal results vs. 1/31 patients with complete deployment success; P < 0.05). Multiple stents implantation did not carry a significant risk of major cardiac adverse events. The results of this study suggest that bailout Palmaz‐Schatz stenting may be considered a stand‐alone treatment of coronary dissection if an optimal acute angiographic result is achieved.

This publication has 23 references indexed in Scilit: